SCHEMBL3345880

SCHEMBL3345880

CC(=O)N(O)c1ccc(-c2ccccc2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.52
MAPT P10636 4/20 0.52
ALDH1A1 P00352 3/20 0.43
KDM4E B2RXH2 3/20 0.43
HPGD P15428 2/20 0.43
USP2 O75604 1/20 0.43
KMT2A Q03164 1/20 0.43
L3MBTL1 Q9Y468 2/20 0.42
PTGS2 P35354 1/20 0.42
ABCC4 O15439 1/20 0.41
LMNA P02545 1/20 0.41
GAA P10253 1/20 0.41
TSHR P16473 1/20 0.41
PTGS1 P23219 1/20 0.41
HTT P42858 1/20 0.41
AGTR1 P30556 1/20 0.41
FASN P49327 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
MGLL Q99685 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL440963 0.87 KDM4E (0.48) SMN1; SMN2MAPTALDH1A1KDM4EHPGD
Water SCHEMBL28741447 0.85 KDM4E (0.47) SMN1; SMN2MAPTALDH1A1KDM4EHPGD
SCHEMBL3297266 0.81 MAPT (0.54) SMN1; SMN2MAPTALDH1A1KDM4EHPGD
SCHEMBL4870751 0.81 MAPT (0.54) SMN1; SMN2MAPTALDH1A1KDM4EHPGD
SCHEMBL1177869 0.79 ALDH1A1 (0.53) SMN1; SMN2MAPTALDH1A1KDM4EUSP2
SCHEMBL3343044 0.79 CTDSP1 (0.62) SMN1; SMN2MAPTALDH1A1KMT2AL3MBTL1
SCHEMBL3343041 0.79 CTDSP1 (0.62) SMN1; SMN2MAPTALDH1A1KMT2AL3MBTL1
Acetohydroxamic Acid SCHEMBL28769569 0.78 MTNR1A (0.44) SMN1; SMN2MAPTALDH1A1KDM4EHPGD
SCHEMBL1948081 0.76 MAPT (0.48) SMN1; SMN2MAPTALDH1A1KDM4EHPGD
SCHEMBL27534541 0.76 KMT2A (0.47) MAPTALDH1A1KDM4EHPGDKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100162416-A1 Multi-stage stem cell carcinogenesis STEMLIFELINE, INC. (US) 2010-06-24 US disclosed
WO-2010037134-A2 MULTI-STAGE STEM CELL CARCINOGENESIS STEMLIFELINE, INC. (US) 2010-04-01 WO disclosed
EP-1137769-B1 METHODS FOR THE GENERATION OF DNA LIBRARIES UNIV ROCHESTER (US) 2008-09-03 EP disclosed
US-20060160129-A1 Methods of producing a library and methods of selecting polynucleotides of interest UNIVERSITY OF ROCHESTER (US) 2006-07-20 US disclosed
US-7067251-B2 Methods of directly selecting cells expressing inserts of interest UNIVERSITY OF ROCHESTER (US) 2006-06-27 US disclosed
US-6872518-B2 Methods for selecting polynucleotides encoding T cell epitopes UNIVERSITY OF ROCHESTER (US) 2005-03-29 US disclosed
US-6800442-B2 Methods of selecting polynucleotides encoding antigens UNIVERSITY OF ROCHESTER 2004-10-05 US disclosed
US-6706477-B2 CELL DIFFERENTIATION; ANTITUMOR, ANTICANCER AGENTS UNIVERSITY OF ROCHESTER 2004-03-16 US disclosed
EP-1137769-A1 T CELLS SPECIFIC FOR TARGET ANTIGENS AND METHODS AND VACCINES BASED THEREON UNIVERSITY OF ROCHESTER (US) 2001-10-04 EP disclosed
WO-2000028016-A1 T CELLS SPECIFIC FOR TARGET ANTIGENS AND METHODS AND VACCINES BASED THEREON UNIVERSITY OF ROCHESTER (US) 2000-05-18 WO disclosed